List of insiders holdings for DURECT CORP:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Insider Holder Name | Report Date Time | Shares Owned Directly Indirectly | Total Shares Owned | Filing |
| First Eagle Investment Management LLC First Eagle Holdings Inc. 10% Owner | 2019-09-04 17:50:09 | 0 26,476,546 | 26,476,546 | Form 4 |
| SCHRECK THOMAS A Chief Financial Officer | 2005-02-17 20:14:14 | 3,022,450 0 | 3,022,450 | Form 13G |
| JIAN LI InterimPrincipalAccountingOfcr | 2022-03-25 19:33:26 | 1,220,782 0 | 1,220,782 | Form 3 |
| Arenberg Michael Chief Financial Officer | 2022-01-10 17:49:05 | 546,350 0 | 546,350 | Form 4 |
| NELSON TIMOTHY S Sr. VP Business & Development | 2004-12-21 20:47:05 | 429,325 25,000 | 454,325 | Form 4 |
| BROWN JAMES E President & CEO | 2024-10-16 16:42:29 | 375,000 0 | 375,000 | Form 4 |
| THEEUWES FELIX Chairman and CSO | 2018-01-30 18:36:44 | 279,428 0 | 279,428 | Form 4 |
| HOGAN MATTHEW J Chief Financial Officer | 2018-01-30 18:37:49 | 278,910 0 | 278,910 | Form 4 |
| YUM SU IL Exec. VP Pharm./R&D | 2015-01-13 18:17:11 | 221,024 0 | 221,024 | Form 4 |
| LIU JEAN I Chief Legal Officer | 2011-07-13 19:25:05 | 184,627 0 | 184,627 | Form 4 |
| Mendenhall Paula V Exec. VP of Operations/Admin. | 2012-02-07 18:58:15 | 156,810 0 | 156,810 | Form 4 |
| Stauffer Joseph William CMO and Exec.VP Corp. Strategy | 2011-01-21 18:51:52 | 125,000 0 | 125,000 | Form 4 |
| Papp Timothy M. Chief Financial Officer | 2024-10-16 16:46:24 | 110,000 0 | 110,000 | Form 4 |
| BENITO SIMON X Director | 2021-12-09 13:35:14 | 105,000 0 | 105,000 | Form 4 |
| Sussman Norman Chief Medical Officer | 2024-10-16 16:47:15 | 104,000 0 | 104,000 | Form 4 |
| GILLIS EDWARD M VP Engineering | 2004-03-02 18:31:35 | 100,000 0 | 100,000 | Form 4 |
| Miksztal Andrew VP Pharmaceutical R&D | 2006-01-10 21:48:29 | 75,000 0 | 75,000 | Form 4 |
| HALLADAY STEVEN VP Clinical and Regulatory | 2006-01-10 20:59:15 | 72,000 0 | 72,000 | Form 4 |
| LANGECKER PETER Chief Medical Officer | 2009-05-26 14:58:06 | 66,000 0 | 66,000 | Form 4 |
| Neukermans Armand Director | 2020-06-18 21:37:41 | 55,000 0 | 55,000 | Form 4 |
| SAXE JON S Director | 2020-06-18 21:38:29 | 55,000 0 | 55,000 | Form 4 |
| HOFFMANN DAVE Director | 2022-06-17 16:10:42 | 55,000 0 | 55,000 | Form 4 |
| CHAN TAI WAH VP Pharma. Research & Develp. | 2005-11-08 21:14:57 | 51,371 1000 | 52,371 | Form 4 |
| TIPTON ARTHUR J Sr.VP Bioerodible Product Dev. | 2004-03-02 18:35:41 | 50,000 0 | 50,000 | Form 4 |
| Joice Judy R Sr. VP Operations & Corp QA | 2023-02-23 13:20:34 | 37,456 0 | 37,456 | Form 4 |
| Shepard Jay Director | 2016-06-23 18:39:46 | 35,000 0 | 35,000 | Form 4 |
| CASEY MICHAEL D Director | 2013-06-26 18:47:19 | 35,000 0 | 35,000 | Form 4 |
| TAYLOR MICHAEL J VP, Non Clinical Research | 2004-04-02 20:51:10 | 29,388 0 | 29,388 | Form 4/A |
| AZAB MOHAMMAD Director | 2024-09-27 16:16:26 | 5,500 0 | 5,500 | Form 4 |
| Blaschke Terrence F Director | 2024-09-27 16:16:52 | 5,500 0 | 5,500 | Form 4 |
| Farfel Gail M Director | 2024-09-27 16:17:16 | 5,500 0 | 5,500 | Form 4 |
| GARCIA PETER S Director | 2024-09-27 16:17:48 | 5,500 0 | 5,500 | Form 4 |
| Maderis Gail J Director | 2024-09-27 16:18:21 | 5,500 0 | 5,500 | Form 4 |
| Robertson Judith J. Director | 2024-09-27 16:18:55 | 5,500 0 | 5,500 | Form 4 |
| Bleichroeder LP 10% Owner | 2023-12-01 16:28:30 | 0 0 | 0 | Form 13G |
| First Eagle Investment Management LLC 21 APRIL FUND L.P. 21 APRIL FUND LTD. First Eagle Value in Biotechnology Master Fund Ltd. First Eagle Holdings Inc. 10% Owner | 2019-09-04 17:27:47 | 0 0 | 0 | Form 13G |